A state-of-the-art review on the involvement of Trx-related signal pathways in the complex pathophysiology of neurological disorders will provide new insights into the mechanisms of the Trx family proteins in neuropsychiatric disorders, thereby revealing candidate biomarkers and new therapeutic drug targets, which may lead to clinical drug development for the treatment of various neuropsychiatric diseases. Here, TXN is linked to nervous system disorder.